Prevention of Human Papillomavirus (HPV) and Vaccination
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Human Papillomavirus Vaccines".
Deadline for manuscript submissions: 31 December 2025 | Viewed by 247
Special Issue Editors
Interests: epidemiology and prevention of infectious diseases; health technology assessment (HTA) and pharmacoeconomic evaluations; seroepidemiology studies of vaccine-preventable infectious diseases; public health policies
Special Issues, Collections and Topics in MDPI journals
Interests: epidemiology and prevention of infectious diseases; health technology assessment of new vaccines and vaccination strategies; seroepidemiology studies of vaccine-preventable infectious diseases; public health policies
Special Issues, Collections and Topics in MDPI journals
Interests: epidemiology and prevention of infectious diseases; surveillance of infectious diseases; seroepidemiology studies of vaccine-preventable infectious diseases; impact assessment of vaccination strategies in the general population and risk groups (healthcare workers, pregnant women, diabetic patients, asplenic patients, and adolescents)
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Human Papillomavirus (HPV) infection can result in cancers in both female and male populations, which could have been prevented by immunization. A secondary form of HPV cervical cancer prevention is also available. The WHO has set goals to reduce the average cervical cancer incidence rate by 10% by 2030, achieving 90% HPV vaccination coverage in girls, 70% screening coverage, and 90% coverage in terms of the treatment of precancerous lesions and invasive cancers. Different HPV vaccination and screening programs are in place worldwide. However, adherence to these preventive activities is frequently suboptimal, with some reports of vaccine hesitancy. The promotion of vaccination and screening is thus needed. Lastly, the assessment of the impact of immunization and screening could be useful to improve vaccination coverage.
This Special Issue aims to provide evidence regarding HPV vaccination and screening results and impact in different countries and settings (adolescents, healthy and treated women, men, MSM, etc.).
In this Special Issue, original research articles and reviews are welcome on research areas that may include (but are not limited to) the following: HPV genotype distribution in different pathologies according to age and sex, current and future HPV vaccination and screening strategies, efficacy and effectiveness of HPV vaccines in different target populations, measurement of HPV vaccination coverage, HPV vaccination after treatment, vaccine hesitancy, strategies to improve HPV vaccination and screening coverage in different target populations, cost-effectiveness of HPV vaccination and screening, and the use of potentially new and simplified diagnostic tests to evaluate preventive programs’ performance.
We look forward to receiving your contributions.
Dr. Sara Boccalini
Prof. Dr. Paolo Bonanni
Dr. Angela Bechini
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- HPV vaccination
- screening
- PAP test
- HPV-DNA test
- HPV vaccine coverage
- vaccine hesitancy
- promotion
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
